Vitruvian Bio, LLC
Baltimore, MD
- UEI
- JHJJANE1ALC6
- CAGE
- 8L4Z5
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 7 St Paul St #1500, Baltimore, MD 21202, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Nimh sbir phase 1 topic 001- point-of-care HIV viral load and drug adherence assays | National Institute on Drug Abuse | $299,999 | |
| An electrochemical self-monitoring device for rapid nucleic acid based testing of HIV-1 | National Institute of Allergy and Infectious Diseases | $299,968 | |
| Sbir phase i | National Institute of Allergy and Infectious Diseases | $300,000 |
About Vitruvian Bio, LLC
Vitruvian Bio, LLC is a small disadvantaged, woman-owned business registered in SAM.gov that specializes in advanced medical research and diagnostic technology development. The company focuses on innovative biomedical solutions, particularly in the realm of infectious disease diagnostics and point-of-care testing technologies. Registered since January 2023, Vitruvian Bio has quickly established itself as a competitive small business participant in federal research and development contracts, primarily working with civilian health research agencies.
The company has consistently secured Small Business Innovation Research (SBIR) Phase I contracts from key National Institutes of Health (NIH) agencies, including the National Institute of Mental Health (NIMH), National Institute of Allergy and Infectious Diseases (NIAID), and Department of Health and Human Services. Its federal contract awards, ranging from $299,968 to $300,000, have been exclusively focused on developing advanced HIV-related diagnostic technologies. Specific projects include creating point-of-care assays for measuring HIV viral load and drug adherence, and developing an electrochemical self-monitoring device for rapid nucleic acid-based HIV-1 testing. These contracts are strategically set aside for small businesses, leveraging Vitruvian Bio's status as a woman-owned and small disadvantaged business to compete for targeted federal research funding. All contracts to date have been firm fixed-price definitive contracts with civilian agencies, demonstrating the company's specialized approach to innovative medical research and diagnostic technology development.
Quick answers
What is Vitruvian Bio, LLC's UEI?
Vitruvian Bio, LLC's Unique Entity ID (UEI) in SAM.gov is JHJJANE1ALC6.
What is Vitruvian Bio, LLC's CAGE code?
Vitruvian Bio, LLC's CAGE code is 8L4Z5.
What is Vitruvian Bio, LLC's primary NAICS code?
Vitruvian Bio, LLC's primary NAICS code is 541713 (Research and Development in Nanotechnology).
Where is Vitruvian Bio, LLC located?
Vitruvian Bio, LLC's physical address in SAM.gov is 7 St Paul St #1500, Baltimore, MD 21202, USA.
Is Vitruvian Bio, LLC registered in SAM.gov?
Yes. Vitruvian Bio, LLC's SAM.gov registration is active through March 23, 2027.
What is Vitruvian Bio, LLC's most recent federal award?
Vitruvian Bio, LLC's most recent federal contract award is Nimh sbir phase 1 topic 001- point-of-care HIV viral load and drug adherence assays (75N95024C00040), from National Institute on Drug Abuse, on September 23, 2024.
On GovTribe
See Vitruvian Bio, LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors